TipRanks
Go Ultimate55% OFF

Keymed Biosciences, Inc. (2162) Balance Sheet

Keymed Biosciences, Inc. Balance Sheet

Keymed Biosciences, Inc.'s total assets for Q2 2026 were $5.67B, an increase of 34.35% from the previous quarter. HK:2162 total liabilities were $1.66B for the fiscal quarter, a 15.21% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 4.22B$ 3.77B$ 3.88B$ 3.93B$ 3.93B
$ 1.44B$ 1.29B$ 896.11M$ 593.10M$ 289.07M
$ 2.78B$ 2.48B$ 2.99B$ 3.34B$ 3.65B

Currency in CNY

Keymed Biosciences, Inc. Debt to Assets

01.5B3B4.5B0 %120 %240 %360 %LiabilitiesDebt to Assets2019202020212022202320242025AssetsLiabilitiesDebt to Assets